cysteamine has been researched along with B16 Melanoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, H; Ito, A; Ito, S; Jimbow, K; Tamura, Y; Torigoe, T; Wakamatsu, K | 1 |
| Chen, W; Chen, Y; Cheng, Y; Chudal, L; Guo, X; Li, Y; Liu, L; Ma, L; Pandey, NK; Ran, X; Ran, Y; Wang, C; Xi, Q; Yang, G; Yao, Z; Zhang, J; Zhang, Q; Zhang, R; Zhao, J | 1 |
| Man, N; Miao, YY; Wan, XM; Wen, LP; Zhang, L; Zheng, F | 1 |
| Demidem, A; Madelmont, JC; Morvan, D; Papon, J | 1 |
| Hasegawa, K; Inoue, S; Ito, S; Olivares, C; Otake, H; Solano, F; Wakamatsu, K; Yukitake, J | 1 |
| Inoue, S; Ito, S; Otake, H; Wakamatsu, K; Yukitake, J | 1 |
| Mahaffey, CL; Mummert, ME; Rudrabhatla, SR | 1 |
| Fujioka, M; Honda, H; Ito, A; Ito, S; Jimbow, K; Wakamatsu, K; Yamashita, T; Yoshida, T | 1 |
| Fujita, K; Hasegawa, K; Inoue, S; Ito, S; Jiménez-Cervantes, C; Ozeki, H; Solano, F; Wakamatsu, K | 1 |
| Ito, S; Kasuga, T; Kitagawa, M; Nemoto, T; Seki, S | 1 |
| Alena, F; Gili, A; Iwashina, T; Jimbow, K | 1 |
| Hasegawa, K; Inoue, S; Ito, S; Wakamatsu, K | 1 |
| Chang, D; Jimbow, K; Samra, S; Shokravi, M; Singh, S; Tandon, M; Thomas, PD | 1 |
| Kelland, LR; Lant, NJ; McKeown, P; Robins, DJ; Rogers, PM; Timoney, MC | 1 |
| Jimbow, K; Yamada, K | 1 |
| Ito, S; Kasuga, T; Matsubara, O; Seki, S; Suzuki, S; Yamada, I | 1 |
| Ito, S; Jimbow, K; Miura, T | 1 |
| Alena, F; Ito, S; Jimbow, K | 1 |
| Engelhardt, R; Ito, S; Jimbow, K; Yamada, K | 1 |
| Fujita, K; Ito, S; Jimbow, K; Miura, S; Ueda, T | 1 |
20 other study(ies) available for cysteamine and B16 Melanoma
| Article | Year |
|---|---|
A Sulfur Containing Melanogenesis Substrate,
Topics: Animals; CD8-Positive T-Lymphocytes; Cysteamine; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenols | 2023 |
Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.
Topics: Animals; Cell Line, Tumor; Copper; Cysteamine; Immunotherapy; Melanoma, Experimental; Mice; Nanoparticles; Oxidative Stress | 2020 |
Autophagy-mediated chemosensitization by cysteamine in cancer cells.
Topics: Animals; Antibiotics, Antineoplastic; Autophagy; Cysteamine; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; HeLa Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 2011 |
Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations.
Topics: Animals; Cysteamine; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Nitrosourea Compounds; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Tumor Cells, Cultured | 2003 |
Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Topics: 3T3 Cells; Acetylcysteine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cysteamine; Glutathione; Inhibitory Concentration 50; Kinetics; Magnetic Resonance Spectroscopy; Melanoma; Melanoma, Experimental; Mice; Models, Chemical; Monophenol Monooxygenase; Phenols; Stereoisomerism; Time Factors; Tyrosine | 2003 |
Comparison of in vivo anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Topics: Animals; Antihypertensive Agents; Antineoplastic Agents; Cell Proliferation; Cysteamine; Hypotension; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pigmentation; Rats; Rats, Inbred SHR; Skin Neoplasms; Stereoisomerism; Xenograft Model Antitumor Assays | 2004 |
Tumor microenvironment modulates hyaluronan expression: the lactate effect.
Topics: Animals; Cysteamine; Glucuronosyltransferase; Green Fluorescent Proteins; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; Lactates; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Peptides; RNA, Messenger; Skin Neoplasms | 2006 |
4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
Topics: Animals; Cations; Combined Modality Therapy; Cysteamine; Hyperthermia, Induced; Liposomes; Magnetics; Melanoma, Experimental; Mice; Nanoparticles; Neoplasm Transplantation; Tumor Cells, Cultured | 2007 |
Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Division; Cell Line; Cell Survival; Cysteamine; Dose-Response Relationship, Drug; Humans; Kinetics; Levodopa; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Monophenol Monooxygenase; Oxidation-Reduction; Oxidoreductases; Proteins; Tumor Cells, Cultured | 1995 |
In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Cycle; Cysteamine; Immunohistochemistry; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nuclear Proteins; Proliferating Cell Nuclear Antigen | 1993 |
Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Topics: Animals; Autoradiography; Buthionine Sulfoximine; Cysteamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutathione; Lung Neoplasms; Melanoma, Experimental; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Phenols | 1994 |
Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
Topics: Animals; Antineoplastic Agents; Biological Transport; Biotransformation; Cell Division; Cysteamine; Glutathione; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Structure-Activity Relationship | 1998 |
Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
Topics: Animals; Antineoplastic Agents; Cystamine; Cysteamine; Humans; Hypopigmentation; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenols; Skin Neoplasms; Tumor Cells, Cultured | 1998 |
Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen.
Topics: Antineoplastic Agents; Cysteamine; Drug Screening Assays, Antitumor; Female; Humans; Indicators and Reagents; Melanoma, Experimental; Ovarian Neoplasms; Phenols; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
Topics: Animals; Antineoplastic Agents; Autoradiography; Chromatography, Affinity; Cysteamine; Cysteine; Electrophoresis, Polyacrylamide Gel; Female; Germ-Free Life; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenols; Radioligand Assay; RNA Cap-Binding Proteins; RNA-Binding Proteins; Substrate Specificity; Tumor Cells, Cultured | 1992 |
The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Survival; Cysteamine; DNA; Melanins; Melanoma, Experimental; Nucleic Acid Synthesis Inhibitors; Tumor Cells, Cultured | 1991 |
The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Division; Cysteamine; Cysteine; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Kinetics; Levodopa; Melanoma, Experimental; Mice; Mice, Inbred Strains; Monophenol Monooxygenase; Neoplasm Transplantation; Phenols; Substrate Specificity | 1990 |
Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.
Topics: Animals; Cysteamine; Female; Hair; Hair Color; Injections, Intraperitoneal; Injections, Subcutaneous; Melanins; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenols; Pigmentation | 1990 |
Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cysteamine; DNA Replication; Humans; Kinetics; Melanins; Melanoma; Melanoma, Experimental; Mice; Tumor Cells, Cultured | 1989 |
Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.
Topics: Animals; Cysteamine; Cysteine; Drug Screening Assays, Antitumor; Female; Hair Color; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Random Allocation; Skin Neoplasms | 1987 |